SCA
DMTK

Sassicaia Capital Advisers’s DermTech, Inc. Common Stock DMTK Stock Holding History

Sassicaia Capital Advisers’s Portfolio DMTK Stock Details DMTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-32,200
Closed -$509K – 35
2021
Q4 		$509K Buy
+32,200
New +$773K 3.51% 9

Other funds holding DMTK

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

Sassicaia Capital Advisers's DMTK Position: Q1 2022 in Review

Sassicaia Capital Advisers sold out of DermTech, Inc. Common Stock (DMTK) in Q1 2022, closing a stake of 32,200 shares — an estimated $509K sold.

Sassicaia Capital Advisers first reported a position in DMTK in Q4 2021 and held it in 1 quarter. The position peaked at $509K in Q4 2021. 151 funds tracked by Wall St. Rank hold DMTK as of Q1 2022.

  • Sassicaia Capital Advisers reported no remaining DermTech, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Sassicaia Capital Advisers sold 32,200 DermTech, Inc. Common Stock shares in Q1 2022, an estimated $509K.
  • Sassicaia Capital Advisers first reported a position in DermTech, Inc. Common Stock in Q4 2021 and held it in 1 quarter.
  • Sassicaia Capital Advisers's DermTech, Inc. Common Stock position peaked at $509K in Q4 2021.
  • 151 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q1 2022.

Based on Sassicaia Capital Advisers's 13F filing for Q1 2022, filed 13 May 2022.